134 related articles for article (PubMed ID: 1858726)
1. Immunization response varies with intensity of acute lymphoblastic leukemia therapy.
Ridgway D; Wolff LJ; Deforest A
Am J Dis Child; 1991 Aug; 145(8):887-91. PubMed ID: 1858726
[TBL] [Abstract][Full Text] [Related]
2. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH
J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156
[No Abstract] [Full Text] [Related]
3. Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid.
Decker MD; Edwards KM; Bradley R; Palmer P
J Pediatr; 1993 Mar; 122(3):410-3. PubMed ID: 8441096
[TBL] [Abstract][Full Text] [Related]
4. Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine.
Anderson P; Pichichero M; Edwards K; Porch CR; Insel R
J Pediatr; 1987 Nov; 111(5):644-50. PubMed ID: 3499499
[TBL] [Abstract][Full Text] [Related]
5. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
[TBL] [Abstract][Full Text] [Related]
6. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines.
Lieberman JM; Greenberg DP; Wong VK; Partridge S; Chang SJ; Chiu CY; Ward JI
J Pediatr; 1995 Feb; 126(2):198-205. PubMed ID: 7844665
[TBL] [Abstract][Full Text] [Related]
7. Haemophilus influenzae type B conjugate vaccines.
Kaplan SL
Pediatr Ann; 1990 Dec; 19(12):712-3, 716-8. PubMed ID: 2280990
[No Abstract] [Full Text] [Related]
8. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b.
Ek T; Mellander L; Hahn-Zoric M; Abrahamsson J
J Pediatr Hematol Oncol; 2004 Nov; 26(11):727-34. PubMed ID: 15543007
[TBL] [Abstract][Full Text] [Related]
9. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
[TBL] [Abstract][Full Text] [Related]
10. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
Marchant CD; Band E; Froeschle JE; McVerry PH
Pediatr Infect Dis J; 1989 Aug; 8(8):508-11. PubMed ID: 2788860
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
12. Vaccines for Haemophilus influenzae type b as models for an otitis vaccine.
Mäkelä PH; Käyhty H; Peltola H; Eskola J
Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S73-5. PubMed ID: 2648298
[No Abstract] [Full Text] [Related]
13. Immunization of leukemic children with Haemophilus conjugate vaccine.
Lange B; Jakacki R; Nasab AH; Luery N; McVerry PH
Pediatr Infect Dis J; 1989 Dec; 8(12):883-4. PubMed ID: 2626288
[No Abstract] [Full Text] [Related]
14. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
[TBL] [Abstract][Full Text] [Related]
15. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591
[No Abstract] [Full Text] [Related]
16. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
[No Abstract] [Full Text] [Related]
17. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
18. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
[TBL] [Abstract][Full Text] [Related]
19. Decline in serum antibody to the capsule of Haemophilus influenzae type b in the immediate postimmunization period.
Daum RS; Sood SK; Osterholm MT; Pramberg JC; Granoff PD; White KE; Granoff DM
J Pediatr; 1989 May; 114(5):742-7. PubMed ID: 2785591
[TBL] [Abstract][Full Text] [Related]
20. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
